DXC vs LH · P/E 7.6, rev $12.64B vs P/E 23, rev $7.27B
DXC Technology Co (DXC) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
DXC Technology Co (DXC) is a information technology services company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported DXC revenue for 2026-03-31 was $12.64B. Net income was $18.0M. Revenue was down 1.8% from 2025-03-31 to 2026-03-31. DXC currently screens at market cap $2.92B and trailing P/E 7.6.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
DXC currently screens at market cap $2.92B and trailing P/E 7.6. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the DXC and LH stock pages for the full models.
Not investment advice.